Mirum Pharmaceuticals, Inc. (MIRM) Total liabilities 2020–2025
Mirum Pharmaceuticals, Inc. (MIRM) total liabilities at each fiscal year-end, per SEC filings.
$528.1MFY2025 · since FY2020: $68.8M → $528.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $528.1M | +18.6% |
| FY2024 | $445.1M | +11.9% |
| FY2023 | $398.0M | +88.7% |
| FY2022 | $210.9M | +20.9% |
| FY2021 | $174.4M | +153.7% |
| FY2020 | $68.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net incomeMIRM Net marginMIRM Gross profitMIRM Gross marginMIRM Operating incomeMIRM Operating marginMIRM Operating cash flowMIRM Free cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Shareholders’ equityMIRM overview →